These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11765134)

  • 1. QSAR of matrix metalloproteinase inhibitor N-[(substituted phenyl)sulfonyl]-N-4-nitrobenzylglycine hydroxamates using LFER model.
    Roy K; Pal DK; De AU; Sengupta C
    Drug Des Discov; 2001; 17(4):315-23. PubMed ID: 11765134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR by LFER model of cytotoxicity data of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives using principal component factor analysis and genetic function approximation.
    Roy K; Leonard JT
    Bioorg Med Chem; 2005 Apr; 13(8):2967-73. PubMed ID: 15781406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
    Roy K; Leonard JT
    J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative QSAR modeling of COX-2 inhibitor 1,2-diarylimidazoles using E-state and physicochemical parameters.
    Chakraborty S; Sengupta C; Roy K
    Indian J Biochem Biophys; 2007 Jun; 44(3):169-75. PubMed ID: 17650586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR analysis of some 5-amino-2-mercapto-1,3,4-thiadiazole based inhibitors of matrix metalloproteinases and bacterial collagenase.
    Jamloki A; Karthikeyan C; Hari Narayana Moorthy NS; Trivedi P
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3847-54. PubMed ID: 16682189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR with electrotopological state atom index: human factor Xa inhibitor N2-aroylanthranilamides.
    Roy K; De AU; Sengupta C
    Drug Des Discov; 2002; 18(1):33-43. PubMed ID: 12375631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR by LFER model of HIV protease inhibitor mannitol derivatives using FA-MLR, PCRA, and PLS techniques.
    Leonard JT; Roy K
    Bioorg Med Chem; 2006 Feb; 14(4):1039-46. PubMed ID: 16213730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the hydrophobicity of 2,4-diphenyl-1,3-oxazoline analogs and QSAR analysis of their ovicidal activity against Tetranychus [corrected] urticae.
    Minakuchi C; Suzuki J; Toda K; Akamatsu M; Nakagawa Y
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4080-4. PubMed ID: 16714112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative structure-activity relationship study on some series of anthranilic acid-based matrix metalloproteinase inhibitors.
    Gupta SP; Kumaran S
    Bioorg Med Chem; 2005 Sep; 13(18):5454-62. PubMed ID: 15993609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR of human factor Xa inhibitor N2-aroylanthranilamides using principal component factor analysis.
    Roy K; De AU; Sengupta C
    Drug Des Discov; 2002; 18(1):23-31. PubMed ID: 12375629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sultam hydroxamates as novel matrix metalloproteinase inhibitors.
    Cherney RJ; Mo R; Meyer DT; Hardman KD; Liu RQ; Covington MB; Qian M; Wasserman ZR; Christ DD; Trzaskos JM; Newton RC; Decicco CP
    J Med Chem; 2004 Jun; 47(12):2981-3. PubMed ID: 15163180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative QSAR modeling of CCR5 receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas.
    Thomas Leonard J; Roy K
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4467-74. PubMed ID: 16806923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.
    Mor M; Rivara S; Lodola A; Plazzi PV; Tarzia G; Duranti A; Tontini A; Piersanti G; Kathuria S; Piomelli D
    J Med Chem; 2004 Oct; 47(21):4998-5008. PubMed ID: 15456244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative structural-activity relationship (QSAR) study for fungicidal activities of thiazoline derivatives against rice blast.
    Song JS; Moon T; Nam KD; Lee JK; Hahn HG; Choi EJ; Yoon CN
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2133-42. PubMed ID: 18299194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.
    Reiter LA; Robinson RP; McClure KF; Jones CS; Reese MR; Mitchell PG; Otterness IG; Bliven ML; Liras J; Cortina SR; Donahue KM; Eskra JD; Griffiths RJ; Lame ME; Lopez-Anaya A; Martinelli GJ; McGahee SM; Yocum SA; Lopresti-Morrow LL; Tobiassen LM; Vaughn-Bowser ML
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3389-95. PubMed ID: 15177439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17O NMR studies of ortho-substituent effects in substituted phenyl tosylates.
    Nummert V; Mäemets V; Piirsalu M; Koppel IA
    Magn Reson Chem; 2012 Oct; 50(10):696-704. PubMed ID: 22936629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR studies on structurally similar 2-(4-methanesulfonylphenyl)pyran-4-ones as selective COX-2 inhibitors: a Hansch approach.
    Prasanna S; Manivannan E; Chaturvedi SC
    Bioorg Med Chem Lett; 2005 Jan; 15(2):313-20. PubMed ID: 15603946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results.
    Kontogiorgis CA; Papaioannou P; Hadjipavlou-Litina DJ
    Curr Med Chem; 2005; 12(3):339-55. PubMed ID: 15723623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-O-isopropyl sulfonamido-based hydroxamates: kinetic characterisation of a series of MMP-12/MMP-13 dual target inhibitors.
    Santamaria S; Nuti E; Cercignani G; Marinelli L; La Pietra V; Novellino E; Rossello A
    Biochem Pharmacol; 2012 Sep; 84(6):813-20. PubMed ID: 22771631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of an orally active matrix metalloproteinase inhibitor.
    Yamamoto S; Nakatani S; Ikura M; Sugiura T; Nishita Y; Itadani S; Ogawa K; Ohno H; Takahashi K; Nakai H; Toda M
    Bioorg Med Chem; 2006 Sep; 14(18):6383-403. PubMed ID: 16765051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.